The US likes to pretend free markets are our principle, but we have completely destroyed every notion of a free two-sided market on healthcare. That's the simple explanation for our outcome.
If this tool could parse drug patents and draw molecular structures with associated data, I know we would pay 200k/yr+ for that service, and there's a market for it.
In my own field, there's an incredibly important application to parse patents and scientific papers, but this would require specific image=>text models in order to get the required information out with high fidelity. Do you guys have plans to enable user supplied workflows where perhaps image patches can be sent to bespoke encoders, or finetunes?
You can use the https://github.com/iterative/datachain mentioned by @dmpetrov to predict and draw (in SaaS) a molecular structure. Not only can you predict, but you can also
- enrich the PDF data with external PDB data,
- calculate and evaluate sequence and structure-based predictions made by multiple custom models,
- and optimize time and resources.
I created some simple examples in this area a few months ago. Feel free to email me at mikhail@iterative.ai if you're interested in sharing my findings.
Human beings are naturally envious and covetous creatures. Everyone loves to talk about other people's love lives, and maintains strong opinions about how they should be, while paradoxically relating to the fact that love makes fools of us all.
Meanwhile journalists rest more and more on sexual politics to elicit interest in a public who is very tired of what they have to say.
How about we build stuff, and let people worry about their own love lives?
If people would actually _measure_ the outcomes of peer review instead of talking about it, I think it would meet a swift end.
Empirically, I find no improvement in reproducibility between arxiv and journals. The costs are incredibly high too.
Like many things in our world peer review is a short lived extrapolation which doesn't resemble it's origins but is regarded as immutable gospel. It matters most if what you need is the respect of academics.
Sure, this may be the perspective of an individual suffering from a mental dependence on a dangerous mind-altering substance, but it deserves equal consideration. (/sarcasm)
Unfortunately, I don't think it's this type of visible but marginal nonsense which perpetuates the SF drug economy. There are simply a lot of people making money on the blight. Private equity funds have piled into methadone treatment, even though other treatments are more evidence-based. No matter the customers are penniless wretches, the government is billed astronomical sums to perpetuate their suffering. These are some of the highest profit margin balance sheets I've ever seen. A public which lacks the stomach to account for whether remediations are evidence-based, collaborates with the cartels to keep the whole thing spinning and shambling.
Walk into any hospital waiting room, and count the dollars disappear to "treat" the dopesickness of a victim. Like the rest of the US healthcare system, it's a galactic obvious grift enabled by regulatory capture, operating in plain sight.
Yes. Before criticizing an efficient solution merely because it has a cost we must explain why the non market solution is a farce of inefficient security theatre.
Private flights have no security whatsoever. They are also much more climate unfriendly. If commercial becomes more of a headache people will press up towards jetshares...
